Skip to content

On The Trail of Deceptive Immune Cells

Dortmund, 28th July 2021

Our immune system is designed to protect us from diseases. But why is it that our own defence cells can even aggravate some diseases such as cancer? This question interests biologist Julia Lill. In January 2020, she began researching specialised immune cells of the innate immune response, the neutrophil granulocytes (neutrophils), in the Biospectroscopy working group at ISAS. The scientist from Essen wants to understand what role these cells play in the microenvironment of a tumour and why they can sometimes even promote its growth.

As a reaction to a tumour, the blood stem cells in the bone marrow produce more neutrophils, which then enter the tumour. Instead of fighting it, the immune cells often develop tumour-promoting properties. For example, they can produce substances that help the abnormal cells make other immune cells, such as the T cells of the adaptive immune system (see info box), 'fall asleep'. The result: the tumour can grow almost entirely unhindered. In order to understand this mechanism including its causes, Lill has compiled a data set of 3,500 involved proteins from neutrophils from the bone marrow, blood or tumour of mice, in order to identify the critical molecules. "When I look at the proteome data, they tell me a story. I can see which proteins of the neutrophils in the tumour are regulated differently compared to normal tissue," reports the 28-year-old. On the basis of her data, researchers can find out which proteins they should examine more closely in order to develop suitable drug targets in the future. A specific drug therapy could thereby block the tumour-promoting properties of the neutrophils.

Neutrophils are relevant in many ways

Lill already investigated the body's immune response through neutrophils for her dissertation, which she completed in spring 2021 with the distinction summa cum laude. Her work at the University Hospital Essen focused on so-called enterohaemorrhagic Escherichia coli, better known as EHEC pathogens. They produce a cell-damaging protein (shigatoxin) that can cause severe inflammatory reactions in the body. Similar as in a tumour, the neutrophils can 'overreact' and therefore harm the body more than protect it.

From ISAS to Harvard

Since July 2021, Lill has been working as a researcher at Harvard University. "Julia has quickly adapted to the proteome analysis technique, which was completely new to her. The first data are extremely interesting. Despite being here for just one and a half years, she already built up a large network at ISAS. We will miss her, but we can now continue on her groundwork with new forces," says Prof. Dr. Matthias Gunzer, head of the Biospectroscopy department at ISAS. In the US, Lill wants to combine her knowledge from her doctoral thesis and research at ISAS to better understand the immune response in the tumour microenvironment using microscopy on living animals (intravital microscopy).

(Cheyenne Peters)

Innate & adaptive immune response

The immune system is the body's defence system. It consists of two parts that have different tasks: The innate (general) immune response, which includes the neutrophils, reacts quickly to foreign substances in the body. However, the involved immune cells hardly distinguish between individual pathogens and are often not sufficiently effective. The cells of the adaptive (specialized) immune response, such as the T cells, take considerably longer, but can specifically attack certain pathogens.

(Cheyenne Peters)

A portrait of Julia Lill.

Dr. Julia Lill research at ISAS dealt with the immune response by neutrophil granulocytes.

© ISAS

Share

Further articles

23rd July 2025

3 Questions for Dr Ali Ata Tuz

In his doctorate, Dr Ali Ata Tuz researched the causes of immunodeficiency after strokes and was already working closely with ISAS at the time. Following this, he subsequently devoted himself to the behaviour of immune cells in the bioimaging research group at ISAS. In this interview, the physician talks about his path from the clinic to application-oriented basic research.

Dr. Ali Ata Tuz sitzt am Konfokalmikroskop und schaut frontal in die Kamera.. Auf dem Bildschirm nebem dem Mirkoskop sind in grün und violett Mikroskopaufnahmen von einer Probe im Mikroskop zu sehen.
8th July 2025

Heart Failure Rarely Occurs on Its Own: ISAS Researchers Develop New Treatment Pillars

The symptoms, subsequent problems and therapeutic challenges of patients with heart failure are increasingly challenging for general practitioners and cardiologists. Doctors are limited in their choice of treatment options, especially for patients with additional diseases. At ISAS, researchers are therefore focussing on broadening the therapeutic spectrum.

Prof. Dr. Kristina Lorenz.
25th June 2025

New Ionisation Method: From Open Questions to Closed Plasma

Mass spectrometry only works with electrically charged, i.e. ionised, particles. Researchers often use plasma for this purpose. In a series of publications, scientists from the Miniaturisation Research Group have shed new light on this ionisation method and presented a completely new type of plasma. This does not require a continuous gas flow and is therefore particularly resource-efficient.

Cayian Tian adjusts the gas supply to the plasma.
11th June 2025

“We essentially ask ourselves the same questions”

In the ISAS cooperation project “The Secret World of the Immune System”, ISAS researchers and artists from the storyLab kiU at Dortmund University of Applied Sciences and Arts brought microscope data to life in an immersive space. Lennart Oberscheidt, research associate and visual effects (VFX) supervisor at storyLab kiU, talks about the special features of the project and the similarities between art and research in an interview.

30th May 2025

What Can't Be Missing From Your Project, Laxmikanth Kollipara?

In many research projects, there is one thing that is essential for success. Perhaps a rare sample or a special device? For Dr Laxmikanth Kollipara, that one thing is a very special pillar from the PIPMet project.

Dr Laxmikanth Kollipara stands in the laboratory holding a silver-coloured column. In the background are HPLC systems.
14th May 2025

“Moving to ISAS changed my whole view on mass spectrometry”

Prof Dr Miloš Filipović is researching the connection between ageing processes and gasotransmitter signalling pathways, in particular hydrogen sulphide. The biochemist headed the ERC Sulfaging group at ISAS from October 2020 until February 2025, at which point he was appointed to the University of Glasgow in Scotland. In this interview, he looks back on the past four and a half years in Dortmund and talks about his experiences at ISAS.

Dr. habil. Milos Filipovic.
30th April 2025

Humboldt Fellow Prof Dr Xiaowei Xu started at ISAS in March

Prof Dr Xiaowei Xu from the Chinese Guangdong Cardiovascular Institute is researching the clinical application of artificial intelligence (AI) in the context of cardiovascular diseases. For 18 months in total, he will be researching various AI methods for analysing cell images as a Humboldt Fellow at ISAS.

Prof Dr Xiaowei Xu in front of the ISAS city building.
22nd April 2025

Valuable Connections: Dr Mohammad Ibrahim AlWahsh

Dr Mohammad Ibrahim AlWahsh worked as a research assistant at ISAS during his doctorate. He is now Vice Dean of the Faculty of Pharmacy and Assistant Professor of Toxicological Pathology at Al-Zaytoonah University in Jordan. In the Kompakt series ‘Valuable Connections,’ he reports on his time at ISAS and his ongoing network with the institute.

Mohammad Alwahsh.
9th April 2025

Bacteria & Sweets: Schoolgirls Examine their Breath at the Girls’ Day

On Girls' Day 2025, twelve schoolgirls got to know the work of researchers and technical assistants at the institute. They investigated the cause of and fight against inflammation, went on the hunt for bacteria and used ion mobility spectrometry to analyze the aromatic substances of various sweets in their breath.

Luisa Speicher erklärt drei Mädchen den Vortexmischer.